Teratogenic potential of some psychopharmacologic drugs: a brief review.
The placenta has been considered a protective barrier between the mother and fetus. Because many drugs pass relatively freely between mother and fetus, the possible causal relationship between drug ingestion and the incidence of birth defects in humans demands critical examination. A brief review of background information about this interaction and an overview of the effects of commonly used drugs are presented.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000662:Amphetamines / Q000009:adverse effects; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D002188:Cannabis; D002491:Central Nervous System Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D009294:Narcotics / Q000009:adverse effects; D011247:Pregnancy; D011446:Prospective Studies; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012189:Retrospective Studies; D012459:Salicylates / Q000009:adverse effects; D013268:Stimulation, Chemical; D014149:Tranquilizing Agents / Q000009:adverse effects
D000662:Amphetamines; D000929:Antidepressive Agents, Tricyclic; D002491:Central Nervous System Agents; D006993:Hypnotics and Sedatives; D009294:Narcotics; D011619:Psychotropic Drugs; D012459:Salicylates; D014149:Tranquilizing Agents; D008238:Lysergic Acid Diethylamide